Literature DB >> 18344032

[Cardiac magnetic resonance imaging in the diagnosis of acute coronary syndrome. Basics and clinical value].

Frank Breuckmann1, Kai Nassenstein, Oliver Bruder, Christiane Buhr, Burkhard Sievers, Jörg Barkhausen, Raimund Erbel, Peter Hunold.   

Abstract

In contrast to chronic myocardial infarction, data concerning the value of cardiac magnetic resonance imaging in patients with acute onset of chest pain are still rare. Even in the presence of characteristic clinical parameters, cardiac magnetic resonance imaging might provide independent evidence especially in the absence of typical ECG alterations and prior to biomarker elevation. Besides the ability to demonstrate wall motion abnormalities cardiac magnetic resonance imaging gains additional potential as to the detection of myocardial edema, microvascular obstruction (no-reflow) and myocardial necrosis. However, cardiac magnetic resonance imaging is expensive and time-consuming, and therefore may not be cost-effective. At present, a lack of sufficient diagnostic and prognostic data would make cardiac magnetic resonance imaging unsuitable for routine stratification of chest pain patients in an emergency department.

Entities:  

Mesh:

Year:  2008        PMID: 18344032     DOI: 10.1007/s00059-008-3110-8

Source DB:  PubMed          Journal:  Herz        ISSN: 0340-9937            Impact factor:   1.443


  3 in total

1.  [Congenital left ventricular aneurysm in a 17-year-old competitive athlete].

Authors:  I M Breker; T Butz; M van Bracht; G Plehn; J Vormbrock; M Prull; H Yeni; A Meissner; H J Trappe
Journal:  Herz       Date:  2012-03       Impact factor: 1.443

2.  Myelination in the hippocampus during development and following lesion.

Authors:  S Meier; A U Bräuer; B Heimrich; R Nitsch; N E Savaskan
Journal:  Cell Mol Life Sci       Date:  2004-05       Impact factor: 9.261

Review 3.  Enzymology of NAD+ homeostasis in man.

Authors:  G Magni; A Amici; M Emanuelli; G Orsomando; N Raffaelli; S Ruggieri
Journal:  Cell Mol Life Sci       Date:  2004-01       Impact factor: 9.261

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.